In vitro
Explore 2 research publications tagged with this keyword
Publications Tagged with "In vitro"
2 publications found
2018
1 publicationIn Vitro Shoot Multiplication and Plant Regeneration of Physalis peruviana L. An Important Medicinal Plant Harvested at IIIM Jammu (J&K)
(Physalis peruviana(L) is a noteworthy helpful plant which has a spot with the family Solanaceae. It is commonly used as individuals prescription and treating for certain afflictions. The powerful in vitro recuperation of Physalis peruviana was practiced from center point, internode and leaf explants on MS medium with B5 supplements and different concentrations and blends of PGRs like BAP,GA3 and 2,4-D.The most noteworthy amounts of various shoots were cultivated from nodal and internodal explantson 3.0 mg/l BAP + 1.5mg/l GA3 + 0.5mg/l 2, 4-D. The high repeat of shoot duplication saw from leaf explants on 2.5 mg/l BAP+1.0mg/l GA3+ 0.5mg/l 2, 4-D.The recouped shoots were moved in to half quality MS medium propped with IBA for root acknowledgment. Built up plantlets were viably acclimatized. The present assessment exhibited powerful in vitro shoot duplication and recuperation limits of Physalis peruviana L.
2012
1 publicationFormulation and In-Vitro Evaluation of Intra Pocket Drug Delivery Device Containing Gatifloxacin for Periodontitis
Dental implant is a pharmaceutical device in the form of strip with very small loading and size of 0.25 sq cm. For site-specific one-time continuous delivery of Gatifloxacin an antimicrobial compound with excellent activity against anaerobic micro-organism in the treatment of periodontal disease was prepared by solvent casting technique using ethyl cellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose K4M and Eudragit RL-100 with dibutylphthalate as plasticizer. The physicochemical parameters like thickness, weight variation, content uniformity and release characteristics were evaluated The drug release was initially high on day one to achieve immediate therapeutic level of drug in pocket, followed by marked fall in release by day two, and progressive moderate release profile to maintain therapeutic level following anomalous transport mechanism. Formulation F6 released 97.34% of drug at the end of 144 h and was considered as best formulation. In vitro antibacterial activity was carried out on Streptococcus mutans .
